{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T08:38:44Z","timestamp":1782290324906,"version":"3.54.5"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS110456"],"award-info":[{"award-number":["NS110456"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG000255"],"award-info":[{"award-number":["AG000255"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG069390"],"award-info":[{"award-number":["AG069390"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s11307-023-01814-9","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T16:23:01Z","timestamp":1680106981000},"page":"704-719","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Identification of a Putative \u03b1-synuclein Radioligand Using an in silico Similarity Search"],"prefix":"10.1007","volume":"25","author":[{"given":"Bieneke","family":"Janssen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsofia","family":"Lengyel-Zhand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Ju","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall G.","family":"Lougee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aladdin","family":"Riad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuiying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Chang","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Lopresti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinayak V.","family":"Pagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Ferrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin A.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chester A.","family":"Mathis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin","family":"Luk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. James","family":"Petersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7645-2869","authenticated-orcid":false,"given":"Robert H.","family":"Mach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,29]]},"reference":[{"key":"1814_CR1","doi-asserted-by":"publisher","first-page":"134316","DOI":"10.1016\/j.neulet.2019.134316","volume":"709","author":"MX Henderson","year":"2019","unstructured":"Henderson MX, Trojanowski JQ, Lee VM (2019) \u03b1-Synuclein pathology in Parkinson\u2019s disease and related \u03b1-synucleinopathies. Neurosci Lett 709:134316","journal-title":"Neurosci Lett"},{"key":"1814_CR2","doi-asserted-by":"crossref","unstructured":"Seibyl JP (2022) Alpha-synuclein PET and Parkinson disease therapeutic trials: ever the twain shall meet? J Nucl Med 63(10):1463\u20131466","DOI":"10.2967\/jnumed.122.263918"},{"issue":"23","key":"1814_CR3","doi-asserted-by":"publisher","first-page":"167859","DOI":"10.1016\/j.jmb.2022.167859","volume":"434","author":"SX Pancoe","year":"2022","unstructured":"Pancoe SX et al (2022) Effects of mutations and post-translational modifications on \u03b1-synuclein in vitro aggregation. J Mol Biol 434(23):167859","journal-title":"J Mol Biol"},{"issue":"6","key":"1814_CR4","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","volume":"51","author":"W Gibb","year":"1988","unstructured":"Gibb W, Lees A (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 51(6):745\u2013752","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"1814_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1365-2990.1989.tb01147.x","volume":"15","author":"W Gibb","year":"1989","unstructured":"Gibb W, Lees A (1989) The significance of the Lewy body in the diagnosis of idiopathic Parkinson\u2019s disease. Neuropathol Appl Neurobiol 15(1):27\u201344","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"S12","key":"1814_CR6","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1002\/mds.20537","volume":"20","author":"KA Jellinger","year":"2005","unstructured":"Jellinger KA, Seppi K, Wenning GK (2005) Grading of neuropathology in multiple system atrophy: proposal for a novel scale. Mov Disord Off J Mov Disord Soc 20(S12):S29\u2013S36","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"4","key":"1814_CR7","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/S0002-9440(10)65226-1","volume":"155","author":"D Dickson","year":"1999","unstructured":"Dickson D et al (1999) Widespread alterations of \u03b1-synuclein in multiple system atrophy. Am J Pathol 155(4):1241\u20131251","journal-title":"Am J Pathol"},{"issue":"8","key":"1814_CR8","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1093\/brain\/awv114","volume":"138","author":"MD Cykowski","year":"2015","unstructured":"Cykowski MD et al (2015) Expanding the spectrum of neuronal pathology in multiple system atrophy. Brain 138(8):2293\u20132309","journal-title":"Brain"},{"key":"1814_CR9","doi-asserted-by":"crossref","unstructured":"Prasad EM, Hung SY (2021) Current therapies in clinical trials of Parkinson\u2019s disease: a 2021 update.\u00a0Pharmaceuticals (Basel) 14(8):717","DOI":"10.3390\/ph14080717"},{"issue":"10","key":"1814_CR10","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1002\/mds.29170","volume":"37","author":"JW Smit","year":"2022","unstructured":"Smit JW et al (2022) Phase 1\/1b Studies of UCB0599, an Oral Inhibitor of \u03b1-Synuclein Misfolding, Including a Randomized Study in Parkinson\u2019s Disease. Mov Disord 37(10):2045\u20132056","journal-title":"Mov Disord"},{"key":"1814_CR11","doi-asserted-by":"crossref","unstructured":"Buddhala C et al (2015) Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease. Ann Clin Transl Neurol 2(10):949\u2013959","DOI":"10.1002\/acn3.246"},{"issue":"7","key":"1814_CR12","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/nan.12402","volume":"43","author":"DJ Covell","year":"2017","unstructured":"Covell DJ et al (2017) Novel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson\u2019s disease. Neuropathol Appl Neurobiol 43(7):604\u2013620","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"9","key":"1814_CR13","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/s41422-018-0075-x","volume":"28","author":"Y Li","year":"2018","unstructured":"Li Y et al (2018) Amyloid fibril structure of alpha-synuclein determined by cryo-electron microscopy. Cell Res 28(9):897\u2013903","journal-title":"Cell Res"},{"issue":"1","key":"1814_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s40336-016-0217-4","volume":"5","author":"PT Kotzbauer","year":"2017","unstructured":"Kotzbauer PT, Tu Z, Mach RH (2017) Current status of the development of PET radiotracers for imaging alpha synuclein aggregates in Lewy bodies and Lewy neurites. Clin Transl Imaging 5(1):3\u201314","journal-title":"Clin Transl Imaging"},{"issue":"47","key":"1814_CR15","doi-asserted-by":"publisher","first-page":"12746","DOI":"10.1039\/D0SC02159H","volume":"11","author":"JJ Ferrie","year":"2020","unstructured":"Ferrie JJ et al (2020) Identification of a nanomolar affinity \u03b1-synuclein fibril imaging probe by ultra-high throughput in silico screening. Chem Sci 11(47):12746\u201312754","journal-title":"Chem Sci"},{"issue":"2","key":"1814_CR16","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1021\/acs.jcim.5b00572","volume":"56","author":"DK Johnson","year":"2016","unstructured":"Johnson DK, Karanicolas J (2016) Ultra-High-Throughput Structure-Based Virtual Screening for Small-Molecule Inhibitors of Protein-Protein Interactions. J Chem Inf Model 56(2):399\u2013411","journal-title":"J Chem Inf Model"},{"issue":"Pt B","key":"1814_CR17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.expneurol.2017.10.003","volume":"298","author":"P Brundin","year":"2017","unstructured":"Brundin P, Dave KD, Kordower JH (2017) Therapeutic approaches to target alpha-synuclein pathology. Exp Neurol 298(Pt B):225\u2013235","journal-title":"Exp Neurol"},{"issue":"11","key":"1814_CR18","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1021\/acschemneuro.8b00177","volume":"9","author":"CJ Hsieh","year":"2018","unstructured":"Hsieh CJ et al (2018) Alpha Synuclein Fibrils Contain Multiple Binding Sites for Small Molecules. ACS Chem Neurosci 9(11):2521\u20132527","journal-title":"ACS Chem Neurosci"},{"issue":"24","key":"1814_CR19","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.1039\/C9CC09849F","volume":"56","author":"Z Lengyel-Zhand","year":"2020","unstructured":"Lengyel-Zhand Z et al (2020) Synthesis and characterization of high affinity fluorogenic alpha-synuclein probes. Chem Commun (Camb) 56(24):3567\u20133570","journal-title":"Chem Commun (Camb)"},{"key":"1814_CR20","doi-asserted-by":"crossref","unstructured":"Sonustun B et al (2022) Pathological relevance of post-translationally modified alpha-synuclein (pSer87, pSer129, nTyr39) in idiopathic Parkinson\u2019s disease and multiple system atrophy. Cells 11(5):906","DOI":"10.3390\/cells11050906"},{"issue":"12","key":"1814_CR21","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.1074\/mcp.R113.032730","volume":"12","author":"AW Schmid","year":"2013","unstructured":"Schmid AW et al (2013) Alpha-synuclein post-translational modifications as potential biomarkers for Parkinson disease and other synucleinopathies. Mol Cell Proteomics 12(12):3543\u201358","journal-title":"Mol Cell Proteomics"},{"key":"1814_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4939-2978-8_1","volume":"1345","author":"B Fauvet","year":"2016","unstructured":"Fauvet B, Lashuel HA (2016) Semisynthesis and enzymatic preparation of post-translationally modified \u03b1-synuclein. Methods Mol Biol 1345:3\u201320","journal-title":"Methods Mol Biol"},{"key":"1814_CR23","doi-asserted-by":"crossref","unstructured":"Kaide S, Watanabe H, Shimizu Y, Iikuni S, Nakamoto Y, Hasegawa M, Itoh K, Ono M\u00a0(2020) Identification and evaluation of bisquinoline scaffold as a new candidate for \u03b1-synuclein-PET imaging. ACS Chem Neurosci\u00a011(24):4254-4261","DOI":"10.1021\/acschemneuro.0c00523"},{"issue":"8","key":"1814_CR24","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1002\/cbic.202000742","volume":"22","author":"B Pan","year":"2021","unstructured":"Pan B et al (2021) Chemoenzymatic semi-synthesis enables efficient production of isotopically labeled \u03b1-synuclein with site-specific tyrosine phosphorylation. ChemBioChem 22(8):1440\u20131447","journal-title":"ChemBioChem"},{"issue":"3","key":"1814_CR25","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1021\/acschembio.9b01038","volume":"15","author":"B Pan","year":"2020","unstructured":"Pan B, Rhoades E, Petersson EJ (2020) Chemoenzymatic semisynthesis of phosphorylated \u03b1-synuclein enables identification of a bidirectional effect on fibril formation. ACS Chem Biol 15(3):640\u2013645","journal-title":"ACS Chem Biol"},{"issue":"33","key":"1814_CR26","doi-asserted-by":"publisher","first-page":"20305","DOI":"10.1073\/pnas.1922741117","volume":"117","author":"K Zhao","year":"2020","unstructured":"Zhao K et al (2020) Parkinson\u2019s disease-related phosphorylation at Tyr39 rearranges \u03b1-synuclein amyloid fibril structure revealed by cryo-EM. Proc Natl Acad Sci 117(33):20305\u201320315","journal-title":"Proc Natl Acad Sci"},{"key":"1814_CR27","doi-asserted-by":"crossref","unstructured":"Zhang S et al (2023) Post-translational modifications of soluble \u03b1-synuclein regulate the amplification of pathological \u03b1-synuclein. Nat Neurosci 26:213\u2013225","DOI":"10.1038\/s41593-022-01239-7"},{"issue":"16","key":"1814_CR28","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM et al (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30(16):2785\u20132791","journal-title":"J Comput Chem"},{"issue":"16","key":"1814_CR29","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1002\/jcc.20289","volume":"26","author":"JC Phillips","year":"2005","unstructured":"Phillips JC et al (2005) Scalable molecular dynamics with NAMD. J Comput Chem 26(16):1781\u20131802","journal-title":"J Comput Chem"},{"issue":"1","key":"1814_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14(1):33\u201338","journal-title":"J Mol Graph"},{"key":"1814_CR31","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1007\/s12035-020-01988-1","volume":"57","author":"A Riad","year":"2020","unstructured":"Riad A et al (2020) The sigma-2 receptor\/TMEM97, PGRMC1, and LDL receptor complex are responsible for the cellular uptake of A\u03b242 and its protein aggregates. Mol Neurobiol 57:3803\u20133813","journal-title":"Mol Neurobiol"},{"issue":"13","key":"1814_CR32","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/S0024-3205(01)01232-2","volume":"69","author":"WE Klunk","year":"2001","unstructured":"Klunk WE et al (2001) Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain. Life Sci 69(13):1471\u20131484","journal-title":"Life Sci"},{"issue":"65","key":"1814_CR33","doi-asserted-by":"publisher","first-page":"9116","DOI":"10.1039\/D2CC02263J","volume":"58","author":"MG Lougee","year":"2022","unstructured":"Lougee MG et al (2022) Harnessing the intrinsic photochemistry of isoxazoles for the development of chemoproteomic crosslinking methods. Chem Commun 58(65):9116\u20139119","journal-title":"Chem Commun"},{"key":"1814_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ et al (2012) National Institute on Aging\u2013Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol 123:1\u201311","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1814_CR35","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG et al (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 89(1):88\u2013100","journal-title":"Neurology"},{"issue":"2","key":"1814_CR36","doi-asserted-by":"publisher","first-page":"e55031","DOI":"10.1371\/journal.pone.0055031","volume":"8","author":"DP Bagchi","year":"2013","unstructured":"Bagchi DP et al (2013) Binding of the radioligand SIL23 to \u03b1-synuclein fibrils in Parkinson disease brain tissue establishes feasibility and screening approaches for developing a Parkinson disease imaging agent. PloS one 8(2):e55031","journal-title":"PloS one"},{"issue":"6","key":"1814_CR37","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1523\/JNEUROSCI.23-06-02086.2003","volume":"23","author":"WE Klunk","year":"2003","unstructured":"Klunk WE et al (2003) The binding of 2-(4\u2032-methylaminophenyl) benzothiazole to postmortem brain homogenates is dominated by the amyloid component. J Neurosci 23(6):2086\u20132092","journal-title":"J Neurosci"},{"issue":"6109","key":"1814_CR38","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","volume":"338","author":"KC Luk","year":"2012","unstructured":"Luk KC et al (2012) Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338(6109):949\u2013953","journal-title":"Science"},{"issue":"1","key":"1814_CR39","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neuroimage.2007.06.032","volume":"38","author":"MM Mirrione","year":"2007","unstructured":"Mirrione MM et al (2007) A novel approach for imaging brain\u2013behavior relationships in mice reveals unexpected metabolic patterns during seizures in the absence of tissue plasminogen activator. Neuroimage 38(1):34\u201342","journal-title":"Neuroimage"},{"issue":"8","key":"1814_CR40","first-page":"1340","volume":"44","author":"JS Karp","year":"2003","unstructured":"Karp JS et al (2003) Performance of a brain PET camera based on anger-logic gadolinium oxyorthosilicate detectors. J Nucl Med 44(8):1340\u20131349","journal-title":"J Nucl Med"},{"key":"1814_CR41","first-page":"153","volume":"8","author":"A DePierro","year":"1989","unstructured":"DePierro A (1989) On some nonlinear iterative relaxation methods in remote sensing. Mat Apl Comput 8:153\u2013166","journal-title":"Mat Apl Comput"},{"issue":"5","key":"1814_CR42","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1109\/42.538946","volume":"15","author":"J Browne","year":"1996","unstructured":"Browne J, De Pierro A (1996) A row-action alternative to the EM algorithm for maximizing likelihood in emission tomography. IEEE Trans Med Imaging 15(5):687\u2013699","journal-title":"IEEE Trans Med Imaging"},{"key":"1814_CR43","doi-asserted-by":"crossref","unstructured":"Daube-Witherspoon ME, Matej S, Karp JS (2001) Assessment of image quality with a fast fully 3D reconstruction algorithm. 2001 IEEE Nuclear Science Symposium Conference Record (Cat. No. 01CH37310), San Diego, pp 2238\u20132242 vol. 4","DOI":"10.1109\/NSSMIC.2001.1009269"},{"key":"1814_CR44","doi-asserted-by":"crossref","unstructured":"Maurer A et al (2020) 11C radiolabeling of anle253b: a putative PET tracer for Parkinson\u2019s disease that binds to \u03b1-synuclein fibrils in vitro and crosses the blood-brain barrier. Chem Med Chem 15(5):411\u2013415","DOI":"10.1002\/cmdc.201900689"},{"issue":"23","key":"1814_CR45","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","volume":"22","author":"Y Cheng","year":"1973","unstructured":"Cheng Y, Prusoff WH (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22(23):3099\u20133108","journal-title":"Biochem. Pharmacol."},{"issue":"1\u20133","key":"1814_CR46","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0014-5793(03)00866-4","volume":"550","author":"A Pang","year":"2003","unstructured":"Pang A et al (2003) Interdomain dynamics and ligand binding: molecular dynamics simulations of glutamine binding protein. FEBS Lett 550(1\u20133):168\u201374","journal-title":"FEBS Lett"},{"issue":"11","key":"1814_CR47","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1093\/jnen\/nly080","volume":"77","author":"J Brettschneider","year":"2018","unstructured":"Brettschneider J et al (2018) Converging Patterns of alpha-Synuclein Pathology in Multiple System Atrophy. J Neuropathol Exp Neurol 77(11):1005\u20131016","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"1814_CR48","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ana.10795","volume":"55","author":"JJ Zarranz","year":"2004","unstructured":"Zarranz JJ et al (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55(2):164\u2013173","journal-title":"Ann Neurol"},{"issue":"15","key":"1814_CR49","doi-asserted-by":"publisher","first-page":"6002","DOI":"10.1021\/acs.jmedchem.5b00571","volume":"58","author":"W Chu","year":"2015","unstructured":"Chu W et al (2015) Design, synthesis, and characterization of 3-(Benzylidene)indolin-2-one derivatives as ligands for alpha-synuclein fibrils. J Med Chem 58(15):6002\u201317","journal-title":"J Med Chem"},{"issue":"5","key":"1814_CR50","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","volume":"47","author":"IG McKeith","year":"1996","unstructured":"McKeith IG et al (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47(5):1113\u20131124","journal-title":"Neurology"},{"issue":"Pt 6","key":"1814_CR51","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1093\/brain\/awq091","volume":"133","author":"A Kikuchi","year":"2010","unstructured":"Kikuchi A et al (2010) In vivo visualization of alpha-synuclein deposition by carbon-11-labelled 2-[2-(2-dimethylaminothiazol-5-yl)ethenyl]-6-[2-(fluoro)ethoxy]benzoxazole positron emission tomography in multiple system atrophy. Brain 133(Pt 6):1772\u20138","journal-title":"Brain"},{"issue":"9","key":"1814_CR52","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nrn3549","volume":"14","author":"DJ Irwin","year":"2013","unstructured":"Irwin DJ, Lee VM-Y, Trojanowski JQ (2013) Parkinson\u2019s disease dementia: convergence of \u03b1-synuclein, tau and amyloid-\u03b2 pathologies. Nat Rev Neurosci 14(9):626\u2013636","journal-title":"Nat Rev Neurosci"},{"issue":"5","key":"1814_CR53","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nsmb.3194","volume":"23","author":"MD Tuttle","year":"2016","unstructured":"Tuttle MD et al (2016) Solid-state NMR structure of a pathogenic fibril of full-length human alpha-synuclein. Nat Struct Mol Biol 23(5):409\u2013415","journal-title":"Nat Struct Mol Biol"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-023-01814-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11307-023-01814-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-023-01814-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T08:28:49Z","timestamp":1729153729000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11307-023-01814-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,29]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["1814"],"URL":"https:\/\/doi.org\/10.1007\/s11307-023-01814-9","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,29]]},"assertion":[{"value":"30 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}